title: Autoimmunity, phospholipid-reacting antibodies and malaria immunity.
abstract: Several questions regarding the production and functioning of autoantibodies (AAb) during malaria infection remain open. Here we provide an overview of studies conducted in our laboratory that shed some light on the questions of whether antiphospholipid antibodies (aPL) and other AAb associated with autoimmune diseases (AID) can recognize Plasmodia antigens and exert anti-parasite activity; and whether anti-parasite phospholipid antibodies, produced in response to malaria, can inhibit phospholipid-induced inflammatory responses and protect against the pathogenesis of severe malaria. Our work showed that sera from patients with AID containing AAb against dsDNA, ssDNA, nuclear antigens (ANA), actin, cardiolipin (aCL) and erythrocyte membrane antigens recognize plasmodial antigens and can, similarly to monoclonal AAb of several specificities including phospholipid, inhibit the growth of P. falciparum in vitro. However, we did not detect a relationship between the presence of anti-glycosylphosphatidylinositol (GPI) antibodies in the serum and asymptomatic malaria infection, although we did register a relationship between these antibodies and parasitemia levels in infected individuals. Taken together, these results indicate that autoimmune responses mediated by AAb of different specificities, including phospholipid, may have anti-plasmodial activity and protect against malaria, although it is not clear whether anti-parasite phospholipid antibodies can mediate the same effect. The potential effect of anti-parasite phospholipid antibodies in malarious patients that are prone to the development of systemic lupus erythematosus or antiphospholipid syndrome, as well as the (possibly protective?) role of the (pathogenic) aPL on the malaria symptomatology and severity in these individuals, remain open questions.
authors.affiliation: Laboratory for Malaria Research, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro and Center for Malaria Research and Training (CPD-Mal), Fiocruz, Rio de Janeiro / Secretary for Health Surveillance (SVS), Ministry of Health, Brazil.
authors.forename: L R
authors.initials: LR
authors.lastname: Gomes
authors.affiliation: Laboratory for Malaria Research, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro and Center for Malaria Research and Training (CPD-Mal), Fiocruz, Rio de Janeiro / Secretary for Health Surveillance (SVS), Ministry of Health, Brazil Department of Pathology, Albert Einstein College of Medicine, The Bronx, New York, USA.
authors.forename: Y C
authors.initials: YC
authors.lastname: Martins
authors.affiliation: Laboratory for Malaria Research, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro and Center for Malaria Research and Training (CPD-Mal), Fiocruz, Rio de Janeiro / Secretary for Health Surveillance (SVS), Ministry of Health, Brazil ctdr@uol.com.br.
authors.forename: M F
authors.initials: MF
authors.lastname: Ferreira-da-Cruz
authors.affiliation: Laboratory for Malaria Research, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro and Center for Malaria Research and Training (CPD-Mal), Fiocruz, Rio de Janeiro / Secretary for Health Surveillance (SVS), Ministry of Health, Brazil.
authors.forename: C T
authors.initials: CT
authors.lastname: Daniel-Ribeiro
mesh_terms: D001323:Autoantibodies / Q000097:blood*; D015551:Autoimmunity; D017261:Glycosylphosphatidylinositols / Q000276:immunology; D006801:Humans; D008288:Malaria / Q000276:immunology*; D018512:Parasitemia / Q000276:immunology; D010743:Phospholipids / Q000276:immunology
chemical_list: D001323:Autoantibodies; D017261:Glycosylphosphatidylinositols; D010743:Phospholipids; C081751:plasmanylinositol glycan
keywords: Antiphospholipid syndrome; anti-DNA antibodies; malaria; systemic lupus erythematosus